Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 13 min ago
Peer-reviewedCC BY-NC-NDJournal of the anus, rectum and colon

Risk of Advanced Colorectal Neoplasia among Patients Undergoing Repeated Colonoscopy Surveillance: A Two-Center Study.

  1. 1Department of Gastroenterology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
  2. 2Oda GI Endoscopy and Gastroenterology Clinic, Kumamoto, Japan.
  3. 3Department of Biostatistics, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Abstract

Postpolypectomy surveillance plays an important role in the prevention of colorectal cancer. However, optimal surveillance intervals for individuals with multiple prior colonoscopies remain unclear. This study aimed to evaluate the association between prior colonoscopy frequency and advanced neoplasia detection rate (ANDR) according to cumulative colorectal neoplasia treatment history using real-world data from individuals with multiple prior colonoscopies. This two-center retrospective study analyzed colonoscopies performed between 2010 and 2020 in patients aged ≥40 years. The number of colonoscopies performed within the preceding five years was routinely recorded for each examination. The primary outcome was ANDR. Surveillance intervals were considered appropriate when the ANDR was ≤7%. Analyses were stratified according to cumulative prior lesion history as follows: none, adenoma, advanced adenoma, intramucosal carcinoma, or invasive carcinoma. Among 22,066 colonoscopies, ANDR was 17.4% at first-ever examination and progressively decreased with increasing recent colonoscopy frequency: 7.2% with no colonoscopy within five years, 3.9% after one, 3.4% after two, and 2.3% after three or more examinations. ANDR remained ≤7% in patients without lesions or with only non-advanced adenomas within an interval of five years or longer before the index colonoscopy. In contrast, ANDR exceeded 7% at intervals of five years or longer in patients with advanced adenoma or intramucosal carcinoma, whereas patients with invasive carcinoma showed persistently high detection rates even at shorter intervals. Low-risk patients showed a persistently low ANDR, whereas closer surveillance may be justified for patients with advanced adenoma, intramucosal carcinoma, or invasive carcinoma.

Related

  1. Helicobacter pylori infection, histological gradient, and lesion phenotype specificity in colorectal neoplasia: a three-group analysis of 1556 adults undergoing colonoscopy in China
    Preventive medicine reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Histopathological Spectrum and Yield of Advanced Neoplasia in Opportunistic Colonoscopy Without Organised Screening: A Single-Centre Cross-Sectional Study from Western Romania
    Alina Anton, Dan Brebu, Meda-Ada Bugi +13
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Age-stratified gradients of colorectal neoplasia and an exploratory endoscopic red-flag composite in a lesion-confirmed screening colonoscopy cohort
    Lina Du, Jingzhi Su, Jihua Dai +9
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  4. Beyond White-Light Colonoscopy: Water Exchange, Image-Enhanced Endoscopy, and Artificial Intelligence for Colorectal Neoplasia Detection—From Single Tools to Combined Strategies: A Scoping Review
    Teodora Spataru, Remus Popescu, Alina Pistritu +2
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  5. Development of a Novel Real-Time Computer-Assisted Colonoscopy Diagnostic Tool for Colorectal Neoplasia and Cancer to Enable Personalized Patient Management: Protocol for a Multicenter Proof-of-Concept Study.
    Olaolu Olabintan, Angelo Brunori, Natalie Halvorsen +21
    JMIR research protocolsPeer-reviewedCC BYFull textOncologyEurope PMC
BibTeX
@article{kawamura2026risk,
  title = {{Risk of Advanced Colorectal Neoplasia among Patients Undergoing Repeated Colonoscopy Surveillance: A Two-Center Study.}},
  author = {Takuji Kawamura and Yasushi Oda and Go Horiguchi and Satoshi Teramukai and Kiyohito Tanaka},
  journal = {Journal of the anus, rectum and colon},
  year = {2026},
  month = oct,
  doi = {10.23922/jarc.2026-047},
  url = {https://europepmc.org/article/MED/42952898},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Risk of Advanced Colorectal Neoplasia among Patients Undergoing Repeated Colonoscopy Surveillance: A Two-Center Study.
AU  - Takuji Kawamura
AU  - Yasushi Oda
AU  - Go Horiguchi
AU  - Satoshi Teramukai
AU  - Kiyohito Tanaka
PY  - 2026
DA  - 2026/10/25
JO  - Journal of the anus, rectum and colon
DO  - 10.23922/jarc.2026-047
UR  - https://europepmc.org/article/MED/42952898
AB  - Postpolypectomy surveillance plays an important role in the prevention of colorectal cancer. However, optimal surveillance intervals for individuals with multiple prior colonoscopies remain unclear. This study aimed to evaluate the association between prior colonoscopy frequency and advanced neoplasia detection rate (ANDR) according to cumulative colorectal neoplasia treatment history using real-world data from individuals with multiple prior colonoscopies. This two-center retrospective study analyzed colonoscopies performed between 2010 and 2020 in patients aged ≥40 years. The number of colonoscopies performed within the preceding five years was routinely recorded for each examination. The primary outcome was ANDR. Surveillance intervals were considered appropriate when the ANDR was ≤7%. Analyses were stratified according to cumulative prior lesion history as follows: none, adenoma, advanced adenoma, intramucosal carcinoma, or invasive carcinoma. Among 22,066 colonoscopies, ANDR was 17.4% at first-ever examination and progressively decreased with increasing recent colonoscopy frequency: 7.2% with no colonoscopy within five years, 3.9% after one, 3.4% after two, and 2.3% after three or more examinations. ANDR remained ≤7% in patients without lesions or with only non-advanced adenomas within an interval of five years or longer before the index colonoscopy. In contrast, ANDR exceeded 7% at intervals of five years or longer in patients with advanced adenoma or intramucosal carcinoma, whereas patients with invasive carcinoma showed persistently high detection rates even at shorter intervals. Low-risk patients showed a persistently low ANDR, whereas closer surveillance may be justified for patients with advanced adenoma, intramucosal carcinoma, or invasive carcinoma.
SN  - 2432-3853
ER  -